Hyperthermia Clinical Trial
Official title:
Complementary and Alternative Medicine Detoxification: Safety and Efficacy
The goal of this study is to assess the feasibility of the approach, conduct a dose-finding
investigation, and obtain pilot data on hyperthermia via sauna to apply in follow-up trials
in the assessment of human chemical body burden reduction, for general wellness,
detoxification, and pain reduction.
The investigators wish to determine if a hyperthermia-based detoxification protocol is
feasible to conduct: including assessment of recruitment, enrollment, retention, protocol
adherence, adverse events, and changes in serum polychlorinated biphenyls (PCBs).
According to our nationwide survey of Naturopathic Physicians regarding use of
detoxification, approximately 80 percent of NDs (Naturopathic Doctors) use some type of
detoxification interventions in clinical practice on a regular basis. Of the interventions
used, 66% of respondents reported using sauna therapy. Of the conditions treated, over 80
percent of practitioners use sauna-based detoxification for "general cleansing/preventive
medicine." This protocol will utilize a sauna as the primary method of detoxification.
Previous studies on hyperthermia-based protocols for detoxification have been
methodologically challenged and are not readily reproducible. Furthermore, there are no
studies in the literature that identify how long of a protocol is tolerated, is feasible in
the general population, or how long is needed to observe PCB (or other pollutant reduction).
Therefore, we will employ a "high-dose" protocol and a "low-dose" protocol, based on ranges
reported in the literature, in order to evaluate dose-finding outcomes to hyperthermia,
including tolerability, retention, and participant-reported outcomes.
High Dose Participants randomized to this group will undergo a protocol consisting of 2
hours of sauna therapy per day, for a minimum of 5 days per week, completed in 3 weeks or
less (21 days). (15 total sessions, 30 hours of sauna). Participants will be able to
schedule visits on any of 7 days per week. Maximum flexibility in hours of operation as well
as flexibility in which days are attended will be utilized to increase likelihood of
retention. A participant may attend visits for 15 consecutive days, should they wish.
Low Dose Participants randomized to this group will undergo a protocol consisting of 1 hour
of sauna therapy per day, for a minimum of 3 days per week, completed in 3 weeks or less (21
days). (9 total sessions, 9 hours of sauna). Participants will be able to schedule visits on
any of 7 days per week. Maximum flexibility in hours of operation as well as flexibility in
which days are attended will be utilized to increase likelihood of retention. Participants
will be able to attend 9 consecutive sessions, should they wish.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04431596 -
Military Alerting System for Monitoring Body Temperature During Active Cooling
|
N/A | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT00940654 -
The Fever and Antipyretic in Critically Illness Evaluation Study
|
N/A | |
Active, not recruiting |
NCT05809453 -
Intranasal Cocaine and Temperature Regulation During Exercise
|
Phase 1/Phase 2 | |
Completed |
NCT04915859 -
Semiconductor Heat Extraction Cooling
|
N/A | |
Completed |
NCT04613843 -
Cold Water Immersion Stirring in Hyperthermic Individuals
|
N/A | |
Completed |
NCT03689478 -
Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT
|
N/A | |
Completed |
NCT02271607 -
The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients
|
N/A | |
Terminated |
NCT01963117 -
Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis
|
N/A | |
Completed |
NCT04596618 -
Impact of ICE on Exercise Performance in the Heat
|
N/A | |
Withdrawn |
NCT05710978 -
Biomarkers to Assess Acute Kidney Injury Risk During Heat Strain
|
N/A | |
Completed |
NCT05586477 -
Diphenhydramine and Sweating
|
Phase 4 | |
Recruiting |
NCT05366270 -
Peripheral Neuroimmune Mechanisms of Hyperthermia
|
N/A | |
Recruiting |
NCT05993910 -
Prospective Hyperthermia Database in Cancer Patients (HT Register)
|
||
Terminated |
NCT04104334 -
Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC
|
N/A | |
Not yet recruiting |
NCT06389604 -
Preparing for Heat Waves - Enhancing Human Thermophysiological Resilience
|
N/A | |
Not yet recruiting |
NCT05274009 -
Protective Cooling Measures to Safeguard Elderly People From Dangerous Summer Heat
|
N/A | |
Terminated |
NCT00796900 -
Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT02546596 -
The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer
|
N/A | |
Completed |
NCT05327764 -
Work-To-Rest Ratios
|
N/A |